An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE)

Mise à jour : Il y a 4 ans
Référence : NCT01689025

Femme et Homme

Extrait

This trial is conducted in Europe and the United States of America (USA). The aim of the trial is to investigate the safety and tolerability of NNC0114-0006 in subjects with systemic lupus erythematosus (SLE) concomitantly treated with stable background therapies.


Critère d'inclusion

  • Inflammation ,Systemic Lupus Erythematosus


Liens